Positive effects of PARP-1 inhibition in KRAS-mutated intrahepatic cholangiocarcinoma is mediated by CHK1 kinase

被引：0
|
作者：
Castven, Darko [1 ]
Keggenhoff, Friederike [2 ]
Stojkovic, Stojan [1 ]
Becker, Diana
Castven, Jovana [1 ]
Zimpel, Carolin [1 ]
Straub, Beate [2 ]
Langer, Harald [1 ]
Hahnel, Patrizia
Kindler, Thomas
Fahrer, Jörg [3 ]
Rourke, Colm O. [4 ]
Ma, Lichun [5 ]
Wang, Xin W. [5 ]
Gaiser, Timo [6 ]
Matter, Matthias [7 ]
Sina, Christian [1 ]
Derer, Stefanie [1 ]
Roessler, Stephanie [8 ]
Kaina, Bernd [2 ]
Andersen, Jesper [4 ]
Galle, Peter [2 ]
Marquardt, Jens [1 ]
机构：
[1] Univ Klinikum Schleswig Holstein, Campus Lubeck, Lubeck, Germany
[2] Johannes Gutenberg Univ Mainz, Univ Med, Mainz, Germany
[3] Tech Univ Kaiserslautern, Kaiserslautern, Germany
[4] Biotech Res & Innovat Ctr, Copenhagen, Denmark
[5] NCI, NIH, Bethesda, MD USA
[6] Univ Med Mannheim, Mannheim, Germany
[7] Univ Spital Basel, Basel, Switzerland
[8] Heidelberg Univ, Heidelberg, Germany
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-230
引用
收藏
页码：S536 / S537
页数：2
相关论文
共 50 条
  • [1] DECIPHERING THE ROLE OF PARP-1 AS A THERAPEUTIC TARGET IN KRAS-MUTATED INTRAHEPATIC CHOLANGIOCARCINOMA
    Mahn, Friederike L.
    Castven, Darko
    Pereira, Sharon P.
    Hartmann, Monika
    Fahrer, Jorg
    Oliveira, Douglas V.
    Andersen, Jesper B.
    Matter, Matthias
    Roessler, Stephanie
    Kaina, Bernd
    Galle, Peter R.
    Marquardt, Jens U.
    HEPATOLOGY, 2019, 70 : 1143A - 1143A
  • [2] Exploring the effects of PARP inhibition on CHK1 activation as a potential determinant of synergy with CHK1 inhibition.
    Wielgos-Bonvallet, Monicka
    Cybulska, Paulina
    Van Oudenhove, Elke
    Jelinic, Petar
    Levine, Douglas A.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 28 - +
  • [3] ING2 loss sensitizes KRAS-mutated NSCLC to WEE1 inhibition through regulation of CHK1 expression.
    Ricordel, Charles
    Thalappilly, Subash
    Archambeau, Jerome
    Chan, Angela
    Nixon, Nancy
    Desrues, Benoit
    Bebb, Gwyn
    Riabowol, Karl
    Pedeux, Remy
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 57 - 57
  • [4] PARP-1 selectively impairs KRAS-driven phenotypic and molecular features in intrahepatic cholangiocarcinoma
    Keggenhoff, Friederike L.
    Castven, Darko
    Becker, Diana
    Stojkovic, Stojan
    Castven, Jovana
    Zimpel, Carolin
    Straub, Beate K.
    Gerber, Tiemo
    Langer, Harald
    Haehnel, Patricia
    Kindler, Thomas
    Fahrer, Joerg
    O'Rourke, Colm J.
    Ehmer, Ursula
    Saborowski, Anna
    Ma, Lichun
    Wang, Xin Wei
    Gaiser, Timo
    Matter, Matthias S.
    Sina, Christian
    Derer, Stefanie
    Lee, Ju-Seog
    Roessler, Stephanie
    Kaina, Bernd
    Andersen, Jesper B.
    Galle, Peter R.
    Marquardt, Jens U.
    GUT, 2024, 73 (10) : 1712 - 1724
  • [5] Polo-like Kinase 1 Inhibition in KRAS-Mutated Metastatic Colorectal Cancer
    Stebbing, Justin
    Bullock, Andrea J.
    CLINICAL CANCER RESEARCH, 2024, 30 (10) : 2005 - 2007
  • [6] CHK1 inhibition as a therapeutic approach in KRAS mutated and squamous cell carcinoma NSCLC patients.
    Morales-Espinosa, Daniela
    Garcia-Roman, Silvia
    Molina-Vila, Miguel Angel
    Capitan, Ana Gimenez
    Bertran-Alamillo, Jordi
    Mendez, Pedro
    Ramirez, Santiago Viteri
    Karachaliou, Niki
    Rosell, Rafael
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Inhibition of checkpoint kinase 1 (Chk1) as a potential therapeutic for pediatric neuroblastoma
    Russell, Mike R.
    Cole, Kristina A.
    Maris, John M.
    CANCER RESEARCH, 2011, 71
  • [8] Regulation of Chk1 kinase by autoinhibition and ATR-mediated phosphorylation
    Katsuragi, Y
    Sagata, N
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 (04) : 1680 - 1689
  • [9] Regulation of Chk1 kinase by autoinhibition and ATR-mediated phosphorylation
    Katsuragil, Yoshinori
    Sagata, Norimki
    CELL STRUCTURE AND FUNCTION, 2004, 29 : 80 - 80
  • [10] Dual Inhibition of GLUT1 and the ATR/CHK1 Kinase Axis Displays Synergistic Cytotoxicity in KRAS-Mutant Cancer Cells
    Erber, Johanna
    Steiner, Joachim D.
    Isensee, Joerg
    Lobbes, Leonard A.
    Toschka, Andre
    Beleggia, Filippo
    Schmitt, Anna
    Kaiser, Rainer W. J.
    Siedek, Florian
    Persigehl, Thorsten
    Hucho, Tim
    Reinhardt, Hans C.
    CANCER RESEARCH, 2019, 79 (19) : 4855 - 4868
12345